Interestingly, losartan, a representative AT1R blocker used to treat clinical DKD, partially reduced the permissive histone methylation observed in db/db mice, and this could explain the reduced expression of PAI-1, MCP-1 and RAGE under losartan treatment [106]. The gene discussed is CCL2; the disease is diabetic kidney disease.